Lung cancer biomarker testing: perspective from Europe
| Autor: | Irene Sansano, Birgit Guldhammer Skov, Izidor Kern, Vibeke G. Dale, Dalma Udovicic-Gagula, Luka Brcic, Zivka Eri, Lina Carvallo, Silvana Smojver-Ježek, Malgorzata Szolkowska, Sven Perner, Fiorella Calabrese, Sisko Anttila, Spasenja Savic Prince, Alex Haragan, Erik Thunnissen, Ales Ryska, Birgit Weynand, Paul Hofman, Diana Leonte, Siobhan Nicholson |
|---|---|
| Přispěvatelé: | HUSLAB, Department of Pathology, HUS Helsinki and Uusimaa Hospital District |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
SELECTION
0301 basic medicine medicine.medical_specialty predictive testing EGFR media_common.quotation_subject 3122 Cancers Respiratory System Review Article on Selected Highlights of the 2019 Pulmonary Pathology Society Biennial Meeting RECOMMENDATIONS 03 medical and health sciences 0302 clinical medicine Health care medicine IMMUNOHISTOCHEMISTRY Intensive care medicine Predictive testing Lung cancer therapy health care Europe Reimbursement media_common Pharmaceutical industry Science & Technology business.industry Public health ASSOCIATION ONCOLOGY Payment 3. Good health PATHOLOGY 030104 developmental biology Therapy Oncology GUIDELINE 030220 oncology & carcinogenesis Biomarker (medicine) 3111 Biomedicine COLLEGE Unavailability business Life Sciences & Biomedicine EXTERNAL QUALITY ASSESSMENT |
| Zdroj: | Translational Lung Cancer Research (TLCR) Thunnissen, E, Weynand, B, Udovicic-Gagula, D, Brcic, L, Szolkowska, M, Hofman, P, Smojver-Ježek, S, Anttila, S, Calabrese, F, Kern, I, Skov, B, Perner, S, Dale, V G, Eri, Z, Haragan, A, Leonte, D, Carvallo, L, Prince, S S, Nicholson, S, Sansano, I & Ryska, A 2020, ' Lung cancer biomarker testing: Perspective from Europe ', Translational lung cancer research, vol. 9, no. 3, pp. 887-897 . https://doi.org/10.21037/tlcr.2020.04.07 Thunnissen, E, Weynand, B, Udovicic-Gagula, D, Brcic, L, Szolkowska, M, Hofman, P, Smojver-Ježek, S, Anttila, S, Calabrese, F, Kern, I, Skov, B, Perner, S, Dale, V G, Eri, Z, Haragan, A, Leonte, D, Carvallo, L, Prince, S S, Nicholson, S, Sansano, I & Ryska, A 2020, ' Lung cancer biomarker testing : perspective from Europe ', Translational Lung Cancer Research, vol. 9, no. 3, pp. 887-897 . https://doi.org/10.21037/tlcr.2020.04.07 Transl Lung Cancer Res |
| Popis: | A questionnaire on biomarker testing previously used in central European countries was extended and distributed in Western and Central European countries to the pathologists participating at the Pulmonary Pathology Society meeting 26-28 June 2019 in Dubrovnik, Croatia. Each country was represented by one responder. For recent biomarkers the availability and reimbursement of diagnoses of molecular alterations in non-small cell lung carcinoma varies widely between different, also western European, countries. Reimbursement of such assessments varies widely between unavailability and payments by the health care system or even pharmaceutical companies. The support for testing from alternative sources, such as the pharmaceutical industry, is no doubt partly compensating for the lack of public health system support, but it is not a viable or long-term solution. Ideally, a structured access to testing and reimbursement should be the aim in order to provide patients with appropriate therapeutic options. As biomarker enabled therapies deliver a 50% better probability of outcome success, improved and unbiased reimbursement remains a major challenge for the future. ispartof: TRANSLATIONAL LUNG CANCER RESEARCH vol:9 issue:3 pages:887-897 ispartof: location:China status: published |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|